Key result
Available guidelines consistently recommend vitamin K and 4F-PCCs for VKA reversal, and specific reversal agents for DOAC reversal in life-threatening bleeding.
Why the study?
Anticoagulation reversal decisions require balancing hemostasis against post-reversal thrombosis, prompting an appraisal of available guidelines and recent clinical data for VKA and DOAC reversal in major bleeding.
Current guidelines show general consensus on using specific reversal agents or 4F-PCCs for severe bleeding associated with VKAs and DOACs.
No takes yet. Share an insight, caveat, or question.
Reinforces guideline-directed reversal in anticoagulant bleeding; confirms recommendation consistency while leaving comparative outcomes open.
Milling et al. (2020) conducted a review in Anticoagulation reversal in major bleeding or urgent invasive procedures. Anticoagulation reversal agents (Vitamin K, 4F-PCCs, specific reversal agents) was evaluated. Available guidelines consistently recommend vitamin K and 4F-PCCs for VKA reversal, and specific reversal agents for DOAC reversal in life-threatening bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: